Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Diana Shipping Inc. Announces Time Charter Contract for m/v Maera
-
SUNation Energy to Ring the Nasdaq Closing Bell on December 16, 2024
-
Oragenics, Inc. Announces Conversion of Preferred Shares and Elimination of Liquidation Preference
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Xeriant Engages Leading Investor Relations and Performance Marketing Firms to Enhance Shareholder Communication and Public Awareness
-
Totaligent, Inc. Successfully Completes PCAOB Audits for 2022 and 2023; Resumes SEC Reporting as a Voluntary Filer
-
FibroGen Appoints David DeLucia as Chief Financial Officer
-
CareCloud Announces Leadership Realignment to Drive 2025 Growth Strategy
-
Correction - Managers' transactions
-
Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
FlexShopper Partners with Tire Agent to Expand Tire Shopping Options for Near-Prime Credit Consumers
-
Upstream Bio Announces Addition to Russell 2000® Index
-
Qu Biologics’ Site Specific Immunomodulator Enables CAR T-cell Cancer Efficacy in Solid Tumor
-
Rio2 Reports on Fenix Gold Mine Progress
-
HYTN Announces Sale and Distribution of GMP Cannabis Products in the UK
-
LGI Homes Opens New Community in Pennsylvania
-
Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics
-
Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)
-
CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing
-
BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in
-
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
-
Greenridge Exploration Pinpoints High Priority Uranium Targets with KorrAI’s Advanced Analysis at its Nut Lake Project
-
Meet Warpie The Wombat: The Hardworking Mascot of Warpcast's Blockchain Revolution and $WARPIE Token Ecosystem
-
DZS FiberLAN Empowers One of Israel’s Most Innovative Hospitality Venues with State-of-the-Art Communications Capabilities
-
Accolade to Announce Fiscal Third Quarter 2025 Financial Results
-
UAV Corp. (UMAV) Reduces Authorized Shares by 1.2 billion, Demonstrating Commitment to Shareholders
-
NV5 Awarded $10 Million in Critical Mineral Geospatial Projects by U.S. Geological Survey
-
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia
-
Vortex Energy Announces Key Insights from Core Logging and Analysis at Robinsons River Salt Project
-
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
-
Meet Warpie The Wombat: The Hardworking Mascot of Warpcast's Blockchain Revolution and $WARPIE Token Ecosystem
-
American Rebel Light Beer Announces Placements of Multi-Case Product Displays at Key Strategic and Premium Retail Accounts Across Tennessee
-
LOBO EV Technologies Expands Robotic Lawn Mower Business in the U.S. and Australia with Strategic Manufacturing and Distribution Agreement
-
CISO Global Announces Strategic Investment to Accelerate Growth and Profitability
-
GlobeTopper and Amino Rewards Announce Strategic Partnership to Enhance Health and Fitness Loyalty Programs
-
Mercurity Fintech Announces Strategic Joint Venture to Expand into AI Hardware Intelligent Manufacturing and Support Liquid Cooling Solutions for World Leading AI Servers
-
Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC Class II
-
ASP Isotopes Issues Letter to Shareholders
-
SPEE3D’S Cold Spray Additive Manufacturing Technology Successfully Prints Metal Parts In Sub-Zero Environments
-
Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer
-
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards
-
TurboCheck and authID Join Forces to Combat Fake Job Candidates
-
4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS
-
Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis
-
Ladybug Resource Group Achieves Record $9.6 Million Revenue
-
REPEAT -- Protest as MPPs come to Stratford on pre-budget tour: Local citizens angry at Ford government for underfunding, privatizing & destroying our public health care plan to make their voices
-
Mindera Health™ Signs Network Provider Agreement with MultiPlan
-
Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics
-
AFEELA Introduces Stingray Karaoke as its In-Car Entertainment Service
-
Newest Release of Quark Publishing Platform NextGen Features Out-of-the-box AI Capabilities and Wider Creative Design Choices that Result in Enterprise Content Strategy Success
